These results may be of use in conceiving new therapies for CRC that might use BRD4 inhibition to control tumor expansion, making it easier for the tumor to be eliminated in place (likely in conjunction with other chemotherapy medicines). The gene discussed is BRD4; the disease is colorectal carcinoma.